Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.
Sugama Y, Miyanishi K, Osuga T, Tanaka S, Hamaguchi K, Ito R, Sakamoto H, Kubo T, Ohnuma H, Murase K, Takada K, Kobune M, Kato J. Sugama Y, et al. Among authors: ohnuma h. JGH Open. 2021 Nov 19;5(12):1335-1343. doi: 10.1002/jgh3.12676. eCollection 2021 Dec. JGH Open. 2021. PMID: 34950776 Free PMC article.
Association between Hepatic Oxidative Stress Related Factors and Activation of Wnt/β-Catenin Signaling in NAFLD-Induced Hepatocellular Carcinoma.
Hamaguchi K, Miyanishi K, Osuga T, Tanaka S, Ito R, Sakamoto H, Kubo T, Ohnuma H, Murase K, Takada K, Nagayama M, Kimura Y, Mizuguchi T, Takemasa I, Kato J. Hamaguchi K, et al. Among authors: ohnuma h. Cancers (Basel). 2022 Apr 20;14(9):2066. doi: 10.3390/cancers14092066. Cancers (Basel). 2022. PMID: 35565198 Free PMC article.
Clinical utility of capsule endoscopy with flexible spectral imaging color enhancement for diagnosis of small bowel lesions.
Sato Y, Sagawa T, Hirakawa M, Ohnuma H, Osuga T, Okagawa Y, Tamura F, Horiguchi H, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Kato J. Sato Y, et al. Among authors: ohnuma h. Endosc Int Open. 2014 Jun;2(2):E80-7. doi: 10.1055/s-0034-1365526. Epub 2014 May 7. Endosc Int Open. 2014. PMID: 26135265 Free PMC article.
Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
Ohnuma H, Sato Y, Onoyama N, Hamaguchi K, Hayasaka N, Sato M, Murase K, Takada K, Miyanishi K, Murakami T, Ito T, Nobuoka T, Takemasa I, Kato J. Ohnuma H, et al. J Cancer Res Clin Oncol. 2021 Aug;147(8):2385-2396. doi: 10.1007/s00432-021-03516-7. Epub 2021 Feb 3. J Cancer Res Clin Oncol. 2021. PMID: 33534051
Case series of three patients with hereditary diffuse gastric cancer in a single family: Three case reports and review of literature.
Hirakawa M, Takada K, Sato M, Fujita C, Hayasaka N, Nobuoka T, Sugita S, Ishikawa A, Mizukami M, Ohnuma H, Murase K, Miyanishi K, Kobune M, Takemasa I, Hasegawa T, Sakurai A, Kato J. Hirakawa M, et al. Among authors: ohnuma h. World J Gastroenterol. 2020 Nov 14;26(42):6689-6697. doi: 10.3748/wjg.v26.i42.6689. World J Gastroenterol. 2020. PMID: 33268956 Free PMC article. Review.
A case of hypervascular tumors in the liver and pancreas: synchronous hepatocellular carcinoma and pancreatic metastasis from renal cell carcinoma 36 years after nephrectomy.
Nakamura H, Tanaka S, Miyanishi K, Kawano Y, Osuga T, Ishikawa K, Yoshida M, Ohnuma H, Murase K, Takada K, Yamaguchi H, Nagayama M, Kimura Y, Takemasa I, Kato J. Nakamura H, et al. Among authors: ohnuma h. Clin Case Rep. 2020 Dec 25;9(2):932-937. doi: 10.1002/ccr3.3691. eCollection 2021 Feb. Clin Case Rep. 2020. PMID: 33598275 Free PMC article.
A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer.
Sato Y, Ohnuma H, Hirakawa M, Takahashi M, Osuga T, Okagawa Y, Murase K, Takada K, Kawano Y, Iyama S, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Okita K, Mizuguchi T, Furuhata T, Hirata K, Kato J. Sato Y, et al. Among authors: ohnuma h. Cancer Chemother Pharmacol. 2015 Mar;75(3):587-94. doi: 10.1007/s00280-014-2672-9. Epub 2015 Jan 11. Cancer Chemother Pharmacol. 2015. PMID: 25577134 Clinical Trial.
157 results